BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 19465519)

  • 21. Cinaciguat, a novel activator of soluble guanylate cyclase, protects against ischemia/reperfusion injury: role of hydrogen sulfide.
    Salloum FN; Das A; Samidurai A; Hoke NN; Chau VQ; Ockaili RA; Stasch JP; Kukreja RC
    Am J Physiol Heart Circ Physiol; 2012 Mar; 302(6):H1347-54. PubMed ID: 22268103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nitric oxide attenuates endothelin-1-induced activation of ERK1/2, PKB, and Pyk2 in vascular smooth muscle cells by a cGMP-dependent pathway.
    Bouallegue A; Daou GB; Srivastava AK
    Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2072-9. PubMed ID: 17644565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional role of the soluble guanylyl cyclase alpha(1) subunit in vascular smooth muscle relaxation.
    Nimmegeers S; Sips P; Buys E; Brouckaert P; Van de Voorde J
    Cardiovasc Res; 2007 Oct; 76(1):149-59. PubMed ID: 17610859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic Activation of Heme Free Guanylate Cyclase Leads to Renal Protection in Dahl Salt-Sensitive Rats.
    Hoffmann LS; Kretschmer A; Lawrenz B; Hocher B; Stasch JP
    PLoS One; 2015; 10(12):e0145048. PubMed ID: 26717150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble guanylate cyclase-alpha1 deficiency selectively inhibits the pulmonary vasodilator response to nitric oxide and increases the pulmonary vascular remodeling response to chronic hypoxia.
    Vermeersch P; Buys E; Pokreisz P; Marsboom G; Ichinose F; Sips P; Pellens M; Gillijns H; Swinnen M; Graveline A; Collen D; Dewerchin M; Brouckaert P; Bloch KD; Janssens S
    Circulation; 2007 Aug; 116(8):936-43. PubMed ID: 17679618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel soluble guanylate cyclase activator with reduced risk of hypotension by short-acting vasodilation.
    Sawabe T; Chiba T; Kobayashi A; Nagasaka K; Aihara K; Takaya A
    Pharmacol Res Perspect; 2019 Apr; 7(2):e00463. PubMed ID: 30873284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular endothelial growth factor causes pulmonary vasodilation through activation of the phosphatidylinositol-3-kinase-nitric oxide pathway in the late-gestation ovine fetus.
    Grover TR; Zenge JP; Parker TA; Abman SH
    Pediatr Res; 2002 Dec; 52(6):907-12. PubMed ID: 12438669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulmonary vascular dysfunction in preterm lambs with chronic lung disease.
    Bland RD; Ling CY; Albertine KH; Carlton DP; MacRitchie AJ; Day RW; Dahl MJ
    Am J Physiol Lung Cell Mol Physiol; 2003 Jul; 285(1):L76-85. PubMed ID: 12626336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphodiesterase 3A expression is modulated by nitric oxide in rat pulmonary artery smooth muscle cells.
    Busch CJ; Graveline AR; Jiramongkolchai K; Liu H; Sanchez LS; Bloch KD
    J Physiol Pharmacol; 2010 Dec; 61(6):663-9. PubMed ID: 21224496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinct molecular requirements for activation or stabilization of soluble guanylyl cyclase upon haem oxidation-induced degradation.
    Hoffmann LS; Schmidt PM; Keim Y; Schaefer S; Schmidt HH; Stasch JP
    Br J Pharmacol; 2009 Jul; 157(5):781-95. PubMed ID: 19466990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation.
    Feelisch M; Kotsonis P; Siebe J; Clement B; Schmidt HH
    Mol Pharmacol; 1999 Aug; 56(2):243-53. PubMed ID: 10419542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dehydroepiandrosterone upregulates soluble guanylate cyclase and inhibits hypoxic pulmonary hypertension.
    Oka M; Karoor V; Homma N; Nagaoka T; Sakao E; Golembeski SM; Limbird J; Imamura M; Gebb SA; Fagan KA; McMurtry IF
    Cardiovasc Res; 2007 Jun; 74(3):377-87. PubMed ID: 17346686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Responsiveness of rat aorta and pulmonary artery to cGMP generators in the presence of thiol or heme oxidant.
    Tawa M; Yamashita Y; Masuoka T; Nakano K; Yoshida J; Nishio M; Ishibashi T
    J Pharmacol Sci; 2019 May; 140(1):43-47. PubMed ID: 31036520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. K+ channel pulmonary vasodilation in fetal lambs: role of endothelium-derived nitric oxide.
    Chang JK; Moore P; Fineman JR; Soifer SJ; Heymann MA
    J Appl Physiol (1985); 1992 Jul; 73(1):188-94. PubMed ID: 1506367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre-conditioning with the soluble guanylate cyclase activator Cinaciguat reduces ischaemia-reperfusion injury after cardiopulmonary bypass.
    Radovits T; Korkmaz S; Miesel-Gröschel C; Seidel B; Stasch JP; Merkely B; Karck M; Szabó G
    Eur J Cardiothorac Surg; 2011 Feb; 39(2):248-55. PubMed ID: 20591683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cinaciguat (BAY 58-2667) improves cardiopulmonary hemodynamics in patients with acute decompensated heart failure.
    Lapp H; Mitrovic V; Franz N; Heuer H; Buerke M; Wolfertz J; Mueck W; Unger S; Wensing G; Frey R
    Circulation; 2009 Jun; 119(21):2781-8. PubMed ID: 19451356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soluble guanylate cyclase activator reverses acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs.
    Evgenov OV; Ichinose F; Evgenov NV; Gnoth MJ; Falkowski GE; Chang Y; Bloch KD; Zapol WM
    Circulation; 2004 Oct; 110(15):2253-9. PubMed ID: 15466650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aerosol delivery of diethylenetriamine/nitric oxide, a nitric oxide adduct, causes selective pulmonary vasodilation in perinatal lambs.
    Cornfield DN; Martin EB; Hampl V; Archer SL
    J Lab Clin Med; 1999 Oct; 134(4):419-25. PubMed ID: 10521090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different influences of extracellular and intracellular superoxide on relaxation through the NO/sGC/cGMP pathway in isolated rat iliac arteries.
    Tawa M; Shimosato T; Iwasaki H; Imamura T; Okamura T
    J Cardiovasc Pharmacol; 2015 Feb; 65(2):160-7. PubMed ID: 25329747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological activation of soluble guanylate cyclase protects the heart against ischemic injury.
    Korkmaz S; Radovits T; Barnucz E; Hirschberg K; Neugebauer P; Loganathan S; Veres G; Páli S; Seidel B; Zöllner S; Karck M; Szabó G
    Circulation; 2009 Aug; 120(8):677-86. PubMed ID: 19667237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.